Optimizing Ventilation to Improve Survival From Out-of-hospital Cardiac Arrest: the OPTIVO Randomized Controlled Trial

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSunnybrook Health Sciences Centre

About this trial

When the heart stops pumping during cardiac arrest, cardiopulmonary resuscitation (CPR) is used to continue pushing blood and providing oxygen to vital organs. CPR involves a combination of chest compressions (to push the blood) and ventilations (to provide oxygen and gas exchange). There is a lot of research that has helped to optimize the provision of chest compressions, however there is considerably less research available to guide ventilations. The current guideline recommendations are based on limited data, and no data that is specific to cardiac arrest patients. There is a recognized need for research to better guide ventilation during CPR. This research will help to better define appropriate ventilation targets for cardiac arrest patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult (>=18 years of age)

presumed cardiac etiology

treated by paramedics

Ventilation monitor utilized

Disqualifiers

Do Not Resuscitate (DNR) order

No use of ventilation monitor

Traumatic cardiac arrest

Pregnant patients

Trial design

Design model

Crossover

Treatments tested in this trial

  • Low Volume Ventilation

    Other intervention

    Patients in cardiac arrest will be ventilated with a volume of 350ml (+/- 50 ml)

  • High Volume Ventilation

    Other intervention

    600ml (+/-50ml)

Treatment groups

1,656 Participants
are divided into 2 treatment groups
Group A: Low Volume (350ml (+/50ml)Experimental treatment 1 intervention
Group B: 600ml (+/-50ml)Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

Return of Spontaneous Circulation

At any time in the prehospital setting as documented by paramedics

Time frame
Prior to arrival at the hospital. This will occur within 1 hr after enrolment in most patients.

Secondary outcomes

1

Survival to Hospital Discharge

Survival at hospital discharge

Time frame
Discharge from hospital is likely to occur within 30 days of the cardiac arrest event for most patients.
2

Survival to Hospital Admission

Survival to hospital admission obtained through administrative datasets

Time frame
Hospital Admission - estimated to occur within 6 hrs of arrival at hospital for most patients.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sunnybrook Health Sciences Centre

Lead sponsor

Zoll Medical Corporation

Collaborator

This trial is not recruiting at the moment. You can still explore other options: